4//SEC Filing
Shoemaker Daniel D 4
Accession 0001209191-21-018932
CIK 0001434316other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:02 PM ET
Size
18.4 KB
Accession
0001209191-21-018932
Insider Transaction Report
Form 4
Shoemaker Daniel D
Chief Technology Officer
Transactions
- Sale
Common stock
2021-03-08$84.20/sh−2,728$229,705→ 76,720 total - Sale
Common stock
2021-03-08$86.70/sh−800$69,360→ 73,020 total - Sale
Common stock
2021-03-08$83.46/sh−2,480$206,989→ 79,448 total - Sale
Common stock
2021-03-08$85.50/sh−2,900$247,956→ 73,820 total - Sale
Common stock
2021-03-08$79.58/sh−4,627$368,236→ 90,095 total - Sale
Common stock
2021-03-08$78.60/sh−3,298$259,236→ 94,722 total - Sale
Common stock
2021-03-08$80.73/sh−5,174$417,722→ 84,921 total - Sale
Common stock
2021-03-08$81.60/sh−2,993$244,224→ 81,928 total
Footnotes (8)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $78.08 to $79.02 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F3]Represents the weighted average sale price of the shares sold ranging from $79.09 to $80.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F4]Represents the weighted average sale price of the shares sold ranging from $80.12 to $81.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F5]Represents the weighted average sale price of the shares sold ranging from $81.19 to $82.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F6]Represents the weighted average sale price of the shares sold ranging from $82.74 to $83.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F7]Represents the weighted average sale price of the shares sold ranging from $83.775 to $84.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- [F8]Represents the weighted average sale price of the shares sold ranging from $84.99 to $85.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001586892
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:02 PM ET
- Size
- 18.4 KB